Treatment

Guadecitabine clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE1
Combination Study of Guadecitabine/ASTX727 and Pembrolizumab
This study looks at combining two medicines, Guadecitabine/ASTX727 and Pembrolizumab, for people with advanced solid tumours, including a type of lung cancer. The main aim is to check if this new combination is safe and what doses work best.
For: Non Small Cell Lung Cancer
United Kingdom